Activation of TLR7/8 may have a dual role in COVID‐19 disease progression, and a clinical trial in China (ChiCTR2000029776) evaluated the effect of induction of TLR pathways for the treatment of COVID‐19. Here, TLR7 is linked to COVID-19.